2024-11-13 - Analysis Report
## Procter & Gamble Co. (PG) Stock Analysis

This report analyzes Procter & Gamble Co. (PG) stock based on the provided data.

**1. Performance vs. S&P 500 (VOO)**

* **Company Overview:** Procter & Gamble Co. is a multinational consumer goods company that manufactures and markets a wide range of products, including household, personal care, and health care items.
* **Cumulative Return:**
    * PG: 107.82%
    * VOO: 179.25%
* **Lag:** PG has lagged behind the S&P 500 by **-71.43%**. This means that PG's cumulative return is 71.43% lower than the S&P 500's.
* **Relative Lag:** PG's current lag is at the **3.14th percentile** of the historical lag range, indicating that the current underperformance is within the historical range.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 11.8% | 18.1% | -26.6% | 0.7 | 216.4 |
| 2016-2018  | 29.3% | 19.7% | -3.0% | 0.5 | 216.5 |
| 2017-2019  | 62.8% | 19.7% | 11.1% | 0.5 | 294.1 |
| 2018-2020  | 67.4% | 22.9% | 20.1% | 0.7 | 327.7 |
| 2019-2021  | 93.5% | 22.9% | -6.5% | 0.7 | 385.2 |
| 2020-2022  | 32.2% | 22.9% | 8.6% | 0.6 | 356.9 |
| 2021-2023  | 14.5% | 22.4% | -20.4% | 0.4 | 345.1 |
| 2022-2024  | 9.6% | 22.4% | -20.7% | 0.4 | 391.0 |

The analysis shows that PG generally exhibits a **lower beta** than the market, indicating a lower volatility compared to the broader market. The **alpha** fluctuates between negative and positive values, highlighting that PG has not consistently outperformed or underperformed the market.

**2. Recent Price Movement**

* **Last Price:** 165.87
* **5-Day Moving Average:** 164.81
* **20-Day Moving Average:** 167.42
* **60-Day Moving Average:** 170.03

The recent price movements indicate that PG is **trading below all three moving averages**. This might suggest a **short-term downtrend**, although a more detailed technical analysis would be needed to confirm.

**3. Technical Indicators**

* **RSI:** 40.95 - The RSI is in the **neutral zone**, indicating neither overbought nor oversold conditions. 
* **PPO:** -0.01 - The PPO is **slightly negative**, suggesting a potential downward momentum.
* **Delta_Previous_Relative_Divergence:** -1.51 (-) - The recent **relative divergence is negative**, hinting at a **short-term downtrend**.
* **Expected Return:** 0.0% - This suggests that over a long-term horizon (2 years or more), PG is expected to return at the same rate as the S&P 500.

**4. Recent Earnings and Forecasts**

| Date        | EPS    | Revenue  |
|-------------|--------|----------|
| 2024-10-18  | 1.65   | 21.74 B$ |
| 2024-04-19  | 1.56   | 20.20 B$ |
| 2024-01-23  | 1.44   | 21.44 B$ |
| 2023-10-18  | 1.89   | 21.87 B$ |
| 2024-10-18  | 1.89   | 21.87 B$ |

The most recent earnings report (2024-10-18) showed that PG beat earnings estimates by **0.05** (actual EPS of 1.65 vs. estimated 1.60). Revenue also came in **above expectations**, with the actual revenue of 21.74 B$ exceeding the estimated 21.56 B$. This strong performance could potentially provide support for the stock price. 

**5. Financial Information**

**1) Revenue and Profitability:**

| Quarter       | Revenue   | Profit Margin |
|-------------|----------|-------------|
| 2024-09-30  | $21.74B  | 52.06%       |
| 2024-06-30  | $20.53B  | 49.60%       |
| 2024-03-31  | $20.20B  | 51.20%       |
| 2023-12-31  | $21.44B  | 52.69%       |
| 2023-09-30  | $21.87B  | 51.99%       |

Procter & Gamble has consistently maintained **strong profitability** with a **high profit margin**, indicating its ability to generate substantial profits from its sales.

**2) Capital and Profitability:**

| Quarter       | Equity    | ROE      |
|-------------|----------|----------|
| 2024-09-30  | $51.84B  | 7.64%    |
| 2024-06-30  | $50.29B  | 6.24%    |
| 2024-03-31  | $50.06B  | 7.50%    |
| 2023-12-31  | $48.53B  | 7.15%    |
| 2023-09-30  | $47.69B  | 9.48%    |

The data shows that PG maintains a **healthy level of equity** and has consistently achieved a **positive return on equity (ROE)**, signifying its ability to generate returns for shareholders using its invested capital.

**6. News and Recent Issues**

* **Earnings Release:** PG recently released its Q3 2024 earnings, exceeding analysts' expectations on both earnings and revenue. 
* **Market Outlook:** PG is a **defensive stock**, often considered a safe haven in times of economic uncertainty.  
* **Analyst Opinions:** Several analysts have issued "buy" and "outperform" ratings on PG, citing its strong brand portfolio, global presence, and consistent dividend payments.

**7. Comprehensive Analysis**

Procter & Gamble is a large-cap, dividend-paying stock with a long history of consistent performance. Despite recent underperformance compared to the S&P 500, PG remains a profitable company with strong financial fundamentals and a strong brand portfolio. However, the stock is currently experiencing a short-term downtrend, as evidenced by its trading below all three moving averages and the negative relative divergence.  

**8. Recommendation**

* **Short-term:** Given the recent price movements and negative technical indicators, a **wait-and-see approach** is recommended for the short term. 
* **Long-term:** PG's strong financial performance and defensive nature make it a potential **long-term investment**. The 0% expected return suggests that PG is expected to perform in line with the S&P 500 over the long term. 

**Note:** This report is for informational purposes only and does not constitute investment advice. 
